MEPAX
Price
$12.48
Change
+$0.12 (+0.97%)
Updated
Dec 20 closing price
RMFCX
Price
$54.73
Change
+$0.55 (+1.02%)
Updated
Dec 20 closing price
Ad is loading...

MEPAX vs RMFCX

Header iconMEPAX vs RMFCX Comparison
Open Charts MEPAX vs RMFCXBanner chart's image
MassMutual Disciplined Value A
Price$12.48
Change+$0.12 (+0.97%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.73
Change+$0.55 (+1.02%)
VolumeN/A
CapitalizationN/A
MEPAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEPAX vs. RMFCX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEPAX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. MEPAX (33.1M). MEPAX pays higher dividends than RMFCX: MEPAX (1.91) vs RMFCX (1.69). MEPAX was incepted earlier than RMFCX: MEPAX (20 years) vs RMFCX (23 years). MEPAX is a more actively managed with annual turnover of: 70.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than MEPAX: RMFCX (250) vs MEPAX (1000). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. MEPAX (0.87). RMFCX return over 5 years is better than : 37.80 vs. MEPAX (-4.38).
MEPAXRMFCXMEPAX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD0.0689.9211%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets33.1M102B0%
Annual Yield % from dividends1.911.69113%
Returns for 1 year0.8711.118%
Returns for 3 years-9.0812.38-73%
Returns for 5 years-4.3837.80-12%
Returns for 10 years-10.5259.36-18%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA